On Thursday, Shares of Chesapeake Energy Corporation (NYSE:CHK), lost -3.81% to $11.11, hitting its lowest level, as U.S. oil prices edged back below $60 a barrel Thursday, extending losses for a second day after government data showed a surprise enhance in inventories of refined fuels such as gasoline.
The benchmark U.S. oil contract was down 40 cents or 0.7% at $59.87 a barrel on the New York Mercantile Exchange. The global Brent contract was down 15 cents or 0.2% at $63.34 a barrel on the ICE Futures Europe exchange. Fox Business Reports.
Chesapeake Energy Corporation engages in the acquisition, exploration, and development of properties for the production of oil, natural gas and natural gas liquids (NGL) from underground reservoirs in the United States.
Shares of Aetna Inc. (NYSE:AET), inclined 3.99% to $132.60, during its last trading session, hitting its highest level.
Veracyte, Inc. (VCYT), a molecular diagnostics company pioneering the field of molecular cytology, declared that it has signed a contract to become part of Aetna’s (NYSE: AET) laboratory network, effective July 1, 2015.
Veracyte administers the Afirma® Thyroid FNA analysis, a proprietary Gene Expression Classifier (GEC) test. The test is used as part of thyroid cancer diagnosis when it is medically necessary to identify benign thyroid nodules among those deemed indeterminate by cytopathology, potentially enabling patients to avoid an unnecessary surgery.
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit administration services, dental, behavioral health, and vision plans on an insured basis, and an employer-funded or administrative basis.
Finally, CVS Health Corporation (NYSE:CVS), ended its last trade with -0.30% loss, and closed at $105.01.
CVS Health Corporation, declared it has reached new clinical affiliations with Sutter Health in California, Millennium Physician Group in Florida, Bryan Health Connect in Nebraska and Mount Kisco Medical Group, PC in New York. These affiliations will assist enhance access to high-quality, affordable health care services for patients. Through these clinical affiliations, CVS Health will provide prescription and visit information to the participating health care organizations by enabling communication between our secured electronic health record (EHR) systems, which will assist enhance clinical care for patients served by the partnering organizations. In addition, patients will continue to have access to clinical support, medication counseling, chronic disease monitoring and wellness programs at CVS/pharmacy stores and MinuteClinic, the retail medical clinic of CVS Health.
CVS/pharmacy presently has more than 7,800 retail pharmacy locations across the U.S. where CVS pharmacists provide counseling to patients to assist them be adherent to their chronic disease medications. In addition, MinuteClinic also plays an important role by providing patients with timely, affordable and high-quality walk-in health care. There are nearly 1,000 MinuteClinic walk-in medical clinics accessible at CVS/pharmacy retail stores. MinuteClinic locations are open seven days a week, offering evening hours with no appointment necessary and most health insurance is accepted. The clinics are staffed by nurse practitioners and physician assistants who provide treatment for common family illnesses and administer wellness and prevention services, counting health-condition monitoring for patients with chronic diseases.
CVS Health Corporation, together with its auxiliaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
